Selumetinib is currently FDA approved for children 2 years and older with symptomatic and inoperable plexiform neurofibromas.

The Industry Expert Theater (IET) brings together Industry leaders and attendees for hour-long, non-accredited educational presentations on the latest in oncology practices, products, services, and ...